RobertS.RosensteinMD

PubMed

• 27 citations
  Antiplatelet therapy in acute coronary syndromes: focus on ticagrelor
  Kade Birkeland, David Parra, Robert Rosenstein
  Journal of Blood Medicine. 2010-09-01
• 7 citations
  Ultrafiltration versus intravenous loop diuretics in patients with acute decompensated heart failure: a meta-analysis of clinical trials
  Mohamad Kabach, Hassan Alkhawam, Sachil Shah, Georges Joseph, Elie Donath
  Acta Cardiologica. 2017-02-28
• 2 citations
  Apixaban in Patients With Atrial Fibrillation After Transfemoral Aortic Valve Replacement
  Brandon Cave, Augustus Hough, David Parra, Robert Rosenstein
  JACC. Cardiovascular Interventions. 2017-05-08

Journal Articles

• Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation  
  Rosenstein R, Parra D, New England Journal of Medicine, 1/1/2011
• "Effective" Plasma Renin Activity: A Derived Measure for Assessing Residual Plasma Renin Activity in Patients Taking Angiotensin-converting Enzyme Inhibitors or Angiot...  
  Sealey JE, Parra D, Rosenstein R, Laragh JH, Hypertension, 1/1/2010
• Letter by Rosenstein and Parra regarding Article, "Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy with Prasugrel in Patients with Diabetes Mellit...  
  Rosenstein RS, Circulation, 1/30/2009
• Bookends - The Reference Management System  
  Rosenstein RS, Physicians and Computers, 1/1/1985
• Procainamide-Induced Thrombocytopenia  
  Rosenstein RS, American Journal of Hematology, 1/1/1984
• Using a Data Base System to Document Procedural Competency  
  Rosenstein RS, Physicians and Computers, 1/1/1984
• Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension  
  Rosenstein RS, New England Journal of Medicine, 1/12/2009
• Ticagrelor versus Clopidogrel in Acute Coronary Syndromes  
  Rosenstein RS, Parra D, New England Journal of Medicine, 1/10/2009
• Cardiac-resynchronization Therapy  
  Rosenstein RS, Parra D, New England Journal of Medicine, 1/31/2011
• Predicting Bleeding Risk in Anticoagulated Patients with Atrial Fibrillation  
  Rosenstein R, DiMaggio E., Journal of the American College of Cardiology, 1/20/2011
• Antiplatelet Therapy in Acute Coronary Syndromes: Focus on Ticagrelor  
  Birkeland K, Parra D, Rosenstein R, Journal of Blood Medicine, 1/31/2010
• Risk of Bleeding with 2 Doses of Dabigatran Compared with Warfarin in Older and Younger Patients with Atrial Fibrillation: An Analysis of the Randomized Evaluation of ...  
  Reynolds S, Parra D, Rosenstein R, Circulation., 1/24/2012
• Dronedarone in High-risk Permanent Atrial Fibrillation  
  Rosenstein R, Woods D, New England Journal of Medicine, 1/22/2012
• Warfarin versus Aspirin in Heart Failure and Sinus Rhythm  
  Shah S, Parra D, Rosenstein R, New England Journal of Medicine, 1/23/2013
• Neprilysin Inhibition for Heart Failure  
  Hough A, Rosenstein R, New England Journal of Medicine, 1/11/2014
• Join now to see all

Lectures

• Update on Lipid Guidelines 
  1/1/2014
• Onset-Offset -Ticagrelor 
  1/1/2009
• ATHENA & ANDROMEDA – dronedarone 
  1/1/2009
• Tigacrelor – PLATO 
  1/1/2009
• Regadenoson – ADVANCE 1 & 2 
  1/1/2009
• Biomarkers 
  1/1/2009
• COURAGE Nuclear Substudy 
  1/1/2008
• Lp-PLA2 (Rancho Bernardo Study) 
  1/1/2008
• Fibrates 
  1/1/2008
• Perioperative Cardiovascular Evaluation 
  1/1/2008
• Stroke & Antiplatelet Therapy 
  1/1/2008
• JUPITER Trial 
  1/1/2008
• COURAGE Trial 
  1/1/2007
• OASIS 5 
  1/1/2007
• Genomewide Association Analysis of CAD Disease 
  1/1/2007
• Rosiglitazone Meta-Analysis 
  1/1/2007
• CHARISMA Subgroup Analysis 
  1/1/2007
• Statins in Aortic Valve Disease 
  1/1/2007
• TRITON TIMI 
  1/18/2007
• The Updated Guidelines 2007 
  1/30/2008
• Acute Coronary Syndrome – Guidelines & Beyond 
  1/14/2009
• ACS/NSTEMI 
  1/20/2012
• Join now to see all